These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

448 related articles for article (PubMed ID: 23591366)

  • 1. Risks and benefits of testosterone therapy in older men.
    Spitzer M; Huang G; Basaria S; Travison TG; Bhasin S
    Nat Rev Endocrinol; 2013 Jul; 9(7):414-24. PubMed ID: 23591366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Benefits and Risks of Testosterone Treatment of Older Men with Hypogonadism.
    Galbiati FF; Goldman AL; Gattu A; Guzelce EC; Bhasin S
    Urol Clin North Am; 2022 Nov; 49(4):593-602. PubMed ID: 36309416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Testosterone therapy in older men: clinical implications of recent landmark trials.
    Grossmann M; Anawalt BD; Yeap BB
    Eur J Endocrinol; 2024 Jul; 191(1):R22-R31. PubMed ID: 38917356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypotestosteronaemia in the aging male: should we treat it?
    Christe N; Meier CA
    Swiss Med Wkly; 2015; 145():w14216. PubMed ID: 26599486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Benefits and risks of testosterone therapy in older men.
    Cardona Attard C; Fava S
    Minerva Urol Nefrol; 2019 Jun; 71(3):217-229. PubMed ID: 30700083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Negative Impact of Testosterone Deficiency and 5α-Reductase Inhibitors Therapy on Metabolic and Sexual Function in Men.
    Traish AM
    Adv Exp Med Biol; 2017; 1043():473-526. PubMed ID: 29224108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Testosterone replacement therapy and cardiovascular risk.
    Gagliano-Jucá T; Basaria S
    Nat Rev Cardiol; 2019 Sep; 16(9):555-574. PubMed ID: 31123340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Testosterone Replacement Therapy for Male Hypogonadism.
    Heidelbaugh JJ; Belakovskiy A
    Am Fam Physician; 2024 Jun; 109(6):543-549. PubMed ID: 38905552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Testosterone supplementation therapy for older men: potential benefits and risks.
    Gruenewald DA; Matsumoto AM
    J Am Geriatr Soc; 2003 Jan; 51(1):101-15; discussion 115. PubMed ID: 12534854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Testosterone deficiency in men with Type 2 diabetes: pathophysiology and treatment.
    Gianatti EJ; Grossmann M
    Diabet Med; 2020 Feb; 37(2):174-186. PubMed ID: 31006133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Benefits and Risks of Testosterone Treatment in Men with Age-Related Decline in Testosterone.
    Rodrigues Dos Santos M; Bhasin S
    Annu Rev Med; 2021 Jan; 72():75-91. PubMed ID: 33217248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endocrinology Update: Testicular Hypogonadism.
    Heidelbaugh JJ
    FP Essent; 2016 Dec; 451():31-41. PubMed ID: 27936533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Testosterone Replacement Therapy and Mortality in Older Men.
    Hackett GI
    Drug Saf; 2016 Feb; 39(2):117-30. PubMed ID: 26482385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Testosterone therapy in hypogonadal patients and the associated risks of cardiovascular events.
    Kharaba ZJ; Buabeid MA; Ibrahim NA; Jirjees FJ; Obaidi HJA; Kaddaha A; Khajehkarimoddini L; Alfoteih Y
    Biomed Pharmacother; 2020 Sep; 129():110423. PubMed ID: 32570122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quality of Life and Sexual Function Benefits of Long-Term Testosterone Treatment: Longitudinal Results From the Registry of Hypogonadism in Men (RHYME).
    Rosen RC; Wu F; Behre HM; Porst H; Meuleman EJH; Maggi M; Romero-Otero J; Martinez-Salamanca JI; Jones TH; Debruyne FMJ; Kurth KH; Hackett GI; Quinton R; Stroberg P; Reisman Y; Pescatori ES; Morales A; Bassas L; Cruz N; Cunningham GR; Wheaton OA;
    J Sex Med; 2017 Sep; 14(9):1104-1115. PubMed ID: 28781213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline.
    Bhasin S; Brito JP; Cunningham GR; Hayes FJ; Hodis HN; Matsumoto AM; Snyder PJ; Swerdloff RS; Wu FC; Yialamas MA
    J Clin Endocrinol Metab; 2018 May; 103(5):1715-1744. PubMed ID: 29562364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Testosterone replacement therapy with long-acting testosterone undecanoate improves sexual function and quality-of-life parameters vs. placebo in a population of men with type 2 diabetes.
    Hackett G; Cole N; Bhartia M; Kennedy D; Raju J; Wilkinson P
    J Sex Med; 2013 Jun; 10(6):1612-27. PubMed ID: 23551886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anabolic applications of androgens for functional limitations associated with aging and chronic illness.
    Bhasin S; Storer T
    Front Horm Res; 2009; 37():163-182. PubMed ID: 19011296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized placebo-controlled trial of testosterone replacement in men with mild Leydig cell insufficiency following cytotoxic chemotherapy.
    Howell SJ; Radford JA; Adams JE; Smets EM; Warburton R; Shalet SM
    Clin Endocrinol (Oxf); 2001 Sep; 55(3):315-24. PubMed ID: 11589674
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 23.